Search Results

Return to List
Results 21–40 of 95
Title Date
21.

Nalbuphine Hydrochloride Use for Intrapartum Analgesia

Number 376

(Reaffirmed 2014)

ABSTRACT Safety concerns have been raised regarding the use of nalbuphine hydrochloride during labor The American College of Obstetricians and Gynecologists finds data are insufficient to recommend any changes in nalbuphine hydrochloride administration at this time Opinion Nalbuphine hydrochloride...

August 2007

PDF Format
22.

Management of Delivery of a Newborn With Meconium-Stained Amniotic Fluid

Number 379

(Reaffirmed 2013)

ABSTRACT In accordance with the new guidelines from the American Academy of Pediatrics and the American Heart Association all infants with meconiumstained amniotic fluid should no longer routinely receive intrapartum suctioning If meconium is present and the newborn is depressed the clinician shou...

September 2007

PDF Format
23.

Human Immunodeficiency Virus

Number 389

ABSTRACT Because human immunodeficiency virus HIV infection often is detected through prenatal and sexually transmitted disease testing an obstetriciangynecologist may be the first health professional to provide care for a woman infected with HIV Universal testing with patient notification and rig...

December 2007

PDF Format
24.

Umbilical Cord Blood Banking

Number 399

(Reaffirmed 2012, Replaces No. 183, April 1997)

ABSTRACT Two types of banks have emerged for the collection and storage of umbilical cord bloodpublic banks and private banks Public banks promote allogenic related or unrelated donation analogous to the current collection of whole blood units in the United States Private banks were initially deve...

February 2008

PDF Format
25.

Surrogate Motherhood

Number 397

ABSTRACT Ethical responsibilities are described for obstetriciangynecologists who choose to participate in surrogacy arrangements by 1 advising couples who are considering surrogacy 2 counseling potential surrogate mothers 3 providing obstetric services for pregnant women participating in surrogac...

February 2008

PDF Format
26.

Direct-to-Consumer Marketing of Genetic Testing

Number 409

Reaffirmed 2014

ABSTRACT Marketing of genetic testing although similar to directtoconsumer advertising of prescription drugs raises additional concerns and considerations These include issues of limited knowledge among patients and health care providers of available genetic tests difficulty in interpretation of g...

June 2008

PDF Format
27.

Ethical Issues in Genetic Testing

Number 410

(Reaffirmed 2014)

ABSTRACT Genetic testing is poised to play an increasing role in the practice of obstetrics and gynecology To assure patients of the highest quality of care physicians should become familiar with the currently available array of genetic tests and the tests limitations Clinicians should be able to ...

June 2008

PDF Format
28.

Prenatal and Perinatal Human Immunodeficiency Virus Testing - Expanded Recommendations

Number 418

(Reaffirmed 2011, Replaces No. 304, November 2004)

ABSTRACT Early identification and treatment of all pregnant women with human immunodeficiency virus HIV is the best way to prevent neonatal disease and improve the womans health Human immunodeficiency virus screening is recommended for all pregnant women after they are notified that they will be t...

September 2008

PDF Format
29.

Spinal Muscular Atrophy

Number 432

Reaffirmed 2014

ABSTRACT Spinal muscular atrophy SMA is an autosomal recessive neurodegenerative disease that results from degeneration of spinal cord motor neurons leading to atrophy of skeletal muscle and overall weakness In current practice patients with a family history of SMA are being offered carrier screen...

May 2009

PDF Format
30.

Optimal Goals for Anesthesia Care in Obstetrics

Number 433

(Replaces No. 256, May 2001)

ABSTRACT A joint statement from the American Society of Anesthesiologists and the American College of Obstetricians and Gynecologists was developed to address issues of concern to both specialties Good obstetric care requires the availability of qualified personnel and equipment to administer gene...

May 2009

PDF Format
31.

Oral Intake During Labor

Number 441

(Reaffirmed 2013)

ABSTRACT There is insufficient evidence to address the safety of any particular fasting period for solids in obstetric patients Expert opinion supports that patients undergoing either elective cesarean delivery or elective postpartum tubal ligation should undergo a fasting period of 68 hours Adher...

September 2009

PDF Format
32.

Preconception and Prenatal Carrier Screening for Genetic Diseases in Individuals of Eastern European Jewish Descent

Number 442

(Reaffirmed 2014, Replaces No. 298, August 2004)

ABSTRACT Certain autosomal recessive disease conditions are more prevalent in individuals of Eastern European Jewish Ashkenazi descent Previously the American College of Obstetricians and Gynecologists recommended that individuals of Eastern European Jewish ancestry be offered carrier screening fo...

October 2009

PDF Format
33.

Air Travel During Pregnancy

Number 443

(Reaffirmed 2014, Replaces No. 264, December 2001)

ABSTRACT In the absence of obstetric or medical complications pregnant women can observe the same precautions for air travel as the general population and can fly safely Pregnant women should be instructed to continuously use their seat belts while seated as should all air travelers Pregnant air t...

October 2009

PDF Format
34.

Maternal Phenylketonuria

Number 449

(Replaces No. 230, January 2000)

ABSTRACT Phenylketonuria PKU is an autosomal recessive disorder of phenylalanine Phe metabolism characterized by a deficiency of the hepatic enzyme phenylalanine hydroxylase an enzyme responsible for the conversion of phenylalanine to tyrosine and elevated levels of Phe and Phe metabolite All wome...

December 2009

PDF Format
35.

Screening for Depression During and After Pregnancy

Number 453

(Reaffirmed 2012)

Abstract Depression is very common during pregnancy and the postpartum period At this time there is insufficient evidence to support a firm recommendation for universal antepartum or postpartum screening There are also insufficient data to recommend how often screening should be done There are mul...

February 2010

PDF Format
36.

Magnesium Sulfate Before Anticipated Preterm Birth for Neuroprotection

Number 455

(Reaffirmed 2013)

ABSTRACT Numerous large clinical studies have evaluated the evidence regarding magnesium sulfate neuroprotection and preterm births The Committee on Obstetric Practice and the Society for MaternalFetal Medicine recognize that none of the individual studies found a benefit with regard to their prim...

March 2010

PDF Format
37.

Preparing for Disasters: Perspectives on Women

Number 457

(Reaffirmed 2014)

ABSTRACT Emergency plans that specifically address the needs of women infants and children during disasters are currently underdeveloped in the United States Pregnant women infants and children are adversely affected by disasters resulting in an increased number of infants with intrauterine growth...

June 2010

PDF Format
38.

Moderate Caffeine Consumption During Pregnancy

Number 462

(Reaffirmed 2013)

ABSTRACT Moderate caffeine consumption less than 200 mg per day does not appear to be a major contributing factor in miscarriage or preterm birth The relationship of caffeine to growth restriction remains undetermined A final conclusion cannot be made at this time as to whether there is a correlat...

August 2010

PDF Format
39.

Carrier Screening for Fragile X Syndrome

Number 469

(Reaffirmed 2014, Replaces No. 338, June 2006)

ABSTRACT Fragile X syndrome is the most common inherited form of mental retardation The syndrome occurs in approximately 1 in 3600 males and 1 in 40006000 females Approximately 1 in 250 females carry the premutation DNAbased molecular analysis is the preferred method of diagnosis for fragile X syn...

October 2010

PDF Format
40.

Smoking Cessation During Pregnancy

Number 471

(Reaffirmed 2013, Replaces No. 316, October 2005)

ABSTRACT Smoking is the one of the most important modifiable causes of poor pregnancy outcomes in the United States and is associated with maternal fetal and infant morbidity and mortality The physical and psychologic addiction to cigarettes is powerful however the compassionate intervention of th...

November 2010

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998